Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Chan Yong SeongYoung Jun ChaiSang Mok LeeSu-Jin KimJune Young ChoiKyu Eun LeeKi-Tae HwangSun Won ParkKa Hee YiPublished in: PloS one (2018)
The aim of this study was to evaluate preoperatively identifiable clinical and ultrasonographic characteristics associated with central lymph node metastasis (CLNM) in clinically node negative papillary thyroid carcinoma (PTC) patients. Records of the patients who underwent thyroidectomy with prophylactic central lymph node dissection due to clinically node negative PTC (size, 1.0-3.0 cm) were reviewed. Of a total of 174 patients, 71 (40.8%) had CLNMs. CLNM was more associated with capsule invasion than capsule non-invasion on ultrasonography (68.4% vs. 37.4%, p = 0.009). In the 155 patients without capsule invasion, a distance from the capsule < 1.9 mm was associated with CLNM in univariable (p = 0.002) and multivariable analysis (p < 0.001). Any PTC patient with a distance from the capsule ≥ 1.9 mm did not have CLNM whereas 40.8% (58/142) of PTC patients with a distance from the capsule < 1.9 mm had CLNM. CLNM was not associated with age, gender, or tumor size on ultrasonography. Distance from capsule ≥ 1.9 mm on preoperative ultrasonography was a significant indicator for not having CLNM in clinically node negative PTC patients. Measuring distance from the capsule on preoperative ultrasonography images could help select patients with PTC who could benefit from prophylactic central lymph node dissection.
Keyphrases
- end stage renal disease
- lymph node metastasis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- lymph node
- magnetic resonance imaging
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- early stage
- patient reported outcomes
- patients undergoing
- contrast enhanced
- deep learning
- rectal cancer
- convolutional neural network
- locally advanced